[go: up one dir, main page]

AR055436A1 - Asociacion de agonistas de los receptores beta 3 y de inhibidores de la recaptacion de monoaminas, composicion farmaceutica que la contiene y su utilizacion en terapeutica - Google Patents

Asociacion de agonistas de los receptores beta 3 y de inhibidores de la recaptacion de monoaminas, composicion farmaceutica que la contiene y su utilizacion en terapeutica

Info

Publication number
AR055436A1
AR055436A1 ARP060104041A ARP060104041A AR055436A1 AR 055436 A1 AR055436 A1 AR 055436A1 AR P060104041 A ARP060104041 A AR P060104041A AR P060104041 A ARP060104041 A AR P060104041A AR 055436 A1 AR055436 A1 AR 055436A1
Authority
AR
Argentina
Prior art keywords
association
therapeutics
pharmaceutical composition
agonists
receptors
Prior art date
Application number
ARP060104041A
Other languages
English (en)
Inventor
Guy Griebel
Jeanne Stemmelin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR055436A1 publication Critical patent/AR055436A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere a la asociacion de al menos un agonista de los receptores beta3 adrenégicos (o agonista beta3) con un inhibidor de la recaptacion de monoaminas (IRMA). La presente también se refiere a una composicion farmacéutica que comprende la asociacion de la presente y su utilizacion en terapéutica.
ARP060104041A 2005-09-19 2006-09-15 Asociacion de agonistas de los receptores beta 3 y de inhibidores de la recaptacion de monoaminas, composicion farmaceutica que la contiene y su utilizacion en terapeutica AR055436A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509528A FR2890862B1 (fr) 2005-09-19 2005-09-19 Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.

Publications (1)

Publication Number Publication Date
AR055436A1 true AR055436A1 (es) 2007-08-22

Family

ID=36384391

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104041A AR055436A1 (es) 2005-09-19 2006-09-15 Asociacion de agonistas de los receptores beta 3 y de inhibidores de la recaptacion de monoaminas, composicion farmaceutica que la contiene y su utilizacion en terapeutica

Country Status (23)

Country Link
US (1) US20080182899A1 (es)
EP (1) EP1928448B1 (es)
JP (1) JP2009508829A (es)
KR (1) KR20080064115A (es)
CN (1) CN101267814A (es)
AR (1) AR055436A1 (es)
AT (1) ATE441407T1 (es)
AU (1) AU2006293801A1 (es)
BR (1) BRPI0616197A2 (es)
CA (1) CA2620235A1 (es)
CR (1) CR9768A (es)
DE (1) DE602006008964D1 (es)
EA (1) EA200800870A1 (es)
EC (1) ECSP088275A (es)
FR (1) FR2890862B1 (es)
IL (1) IL189755A0 (es)
MA (1) MA30002B1 (es)
NO (1) NO20081723L (es)
NZ (1) NZ566310A (es)
TN (1) TNSN08095A1 (es)
TW (1) TW200744571A (es)
WO (1) WO2007034056A1 (es)
ZA (1) ZA200802544B (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
US5288749A (en) * 1991-12-20 1994-02-22 Abbott Laboratories Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
US6288749B1 (en) * 1996-11-16 2001-09-11 Altec Lansing Technologies, Inc. Computer system with remote television display
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
KR20060087560A (ko) * 2003-09-12 2006-08-02 워너-램버트 캄파니 엘엘씨 알파-2-델타 리간드 및 ｓｓｒｉ 및/또는 ｓｎｒｉ를포함하는 우울증 및 불안 장애 치료용 조합물

Also Published As

Publication number Publication date
DE602006008964D1 (de) 2009-10-15
BRPI0616197A2 (pt) 2011-06-14
ATE441407T1 (de) 2009-09-15
ZA200802544B (en) 2009-08-26
CN101267814A (zh) 2008-09-17
FR2890862B1 (fr) 2008-01-25
JP2009508829A (ja) 2009-03-05
MA30002B1 (fr) 2008-12-01
AU2006293801A1 (en) 2007-03-29
IL189755A0 (en) 2008-12-29
EP1928448A1 (fr) 2008-06-11
CA2620235A1 (fr) 2007-03-29
NO20081723L (no) 2008-05-29
NZ566310A (en) 2010-03-26
EA200800870A1 (ru) 2008-08-29
KR20080064115A (ko) 2008-07-08
FR2890862A1 (fr) 2007-03-23
EP1928448B1 (fr) 2009-09-02
CR9768A (es) 2008-09-23
TNSN08095A1 (en) 2009-07-14
TW200744571A (en) 2007-12-16
WO2007034056A1 (fr) 2007-03-29
ECSP088275A (es) 2008-04-28
US20080182899A1 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
ECSP088222A (es) Agonistas de receptores adrenérgicos alfa2c funcionalmente selectivos
NZ740644A (en) Glucagon receptor agonists
BRPI0913457A2 (pt) "composto, composição farmacêutica, e, uso do composto"
AR064736A1 (es) Agonistas de gpcr
CL2008002159A1 (es) Compuestos derivados de n-(((1r, 4r)-4-aminociclohexil)metil) sulfonaminas sustituidas con heterociclos, antagonistas del receptor npy y5; composicion farmaceutica que comprende a dichos compuestos, utiles para tratar anorexia y obesidad.
IL197294A0 (en) Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the ??2 adrenergic receptor
CL2007003791A1 (es) Compuestos derivados de piperidina, inhibidores de la proteina quinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para inhibir el crecimiento celular anormal.
CL2008001017A1 (es) Compuestos derivados de indol, activadores de glucoquinasa; composicion farmaceutica que los comprende; y su uso para la prevencion o el tratamiento de diabetes u obesidad.
UY29479A1 (es) Inhibidores de adn-pk
MX2010008875A (es) Agonistas nicotinicos alfa 7 y antipsicoticos.
DK2035379T3 (da) Inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1
CR9664A (es) Inhibidores de histona deacetilasa
MEP6208A (en) The combination of a serotonin reuptake inhibitor and a 5-ht¿2c? antagonist, inverse agonist or partial agonist
CL2007001451A1 (es) Compuestos derivados de [1,2,3]-tiazol-4-ilmetoxilo, agonista del receptor farnesoide x (fxr); composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dislipidemia y enfermedades relacionadas.
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
CL2007003793A1 (es) Metodo para inhibir union del receptor de muerte 6 (dr6) a la proteina precursora amiloide (app) que comprende uno o mas antagonistas del dr6; uso de dichos antagonistas; metodo para identificar una molecula de interes que inhibe la union del dr6 a l
GT200900187A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso los mismos
CL2007001391A1 (es) Compuestos derivados de pirrolidinas sustituidas, inhibidores del factor xa y/o inhibidores sobre la serina proteasa; composicion farmaceutica que comprende a dichos compuestos; proedimiento para preparar la composicon farmaceutica; y uso de los compuestos preparar un medicamneto con un efecto antitrombotico
CL2009000262A1 (es) Imidazolin-2,5 dionas bencil-benzoico sustituidas, composicion farmaceutica que contenga estos compuestos y su uso en el sindrome metabolico, obesidad, diabetes, transtornos del snc, esquizofrenia, alzheimer, dependencia al alcohol y nicotina.
AR059445A1 (es) Composiciones de antimicoticos ramnolipidicos y metodos de uso relacionados
GT200500246A (es) Combinacion de compuestos organicos
PE20080908A1 (es) Agonistas lxr para el tratamiento de osteoartritis
CL2007003556A1 (es) Compuestos derivados de 6-(piperidin-4-ilamino)piridazin-3-carbonitrilos, antagonistas del receptor de dopamina 2 de rapida disociacion; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el
CO6260011A2 (es) Uso de (4-metoxi-7-morfolin-4-il-benzotiazol-2-il)-amida del acido 4-hidroxi-4-metil-piperidin-1- carboxilico para el tratamiento del trastorno por estres postraumatico
CL2009000261A1 (es) Imidazolin-2,4 dionas metil fenoxi sustituidas, composicion farmaceutica que contenga estos compuestos y su uso en el sindrome metabolico, obesidad, diabetes, transtornos del snc, esquizofrenia, alzheimer, dependencia al alcohol y a la nicotina.

Legal Events

Date Code Title Description
FB Suspension of granting procedure